Seven Bridge Financial Group, LLC Alaunos Therapeutics, Inc. Transaction History

Seven Bridge Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	SELL	$0.04 - $0.13 $400 - $1,300	-10,000 Reduced 50.0%	10,000 $0
Q3 2022 Oct 17, 2022	BUY	$1.04 - $322.5 $20,800 - $6.45 Million	20,000 New	20,000 $34,000
Q4 2018 Feb 14, 2019	SELL	$1.61 - $3.62 $322 - $724	-200 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	200	200 $1,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.